Combination of benzoyl peroxide 5% gel with liquid cleanser and moisturizer SPF 30 in acne treatment results in high levels of subject satisfaction, good adherence and favorable tolerability

被引:8
作者
Kim, Mi-Ran [1 ]
Kerrouche, Nabil [2 ]
机构
[1] Proinnovera GmbH, Ctr Dermatol Excellence, Munster, Germany
[2] Galderma R&D, Sophia Antipolis, France
关键词
Acne; benzoyl peroxide 5%; liquid cleanser; moisturizer SPF 30; adherence; IMPROVE OUTCOMES; GLOBAL ALLIANCE; MANAGEMENT; THERAPY; SKIN; VULGARIS;
D O I
10.1080/09546634.2017.1342758
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Skin care products (cleansers and moisturizers) to complement benzoyl peroxide (BPO) in the treatment of acne may improve treatment tolerability and adherence.Objective: Evaluate subject satisfaction after use of BPO 5% gel in combination with liquid cleanser and moisturizer SPF 30.Methods: Open-label study including subjects aged 12years with mild-to-moderate facial acne; ClinicalTrials.gov Identifier: NCT02589405. Once daily BPO 5% gel, twice daily liquid cleanser and once daily moisturizer SPF 30 were applied for 12weeks. Assessments included a subject satisfaction questionnaire, investigator global assessment of improvement, lesion counts, the presence of Propionibacterium acnes, and safety.Results: Fifty subjects were enrolled. Most subjects were overall satisfied with the three-part regimen (87%) and felt better about themselves (94%). Subjects indicated the skin care products helped prepare the skin for treatment (85%), relieve itchy skin (81%) and reduce irritation (87%). Most subjects considered that the liquid cleanser (80%) and moisturizer SPF 30 (84%) were a necessary part of acne treatment. BPO reduced P. acnes load by 89% at week 1. The treatment was well tolerated.Conclusions: The combination of BPO 5% gel with liquid cleanser and moisturizer SPF 30 resulted in high levels of subject satisfaction, good tolerability and treatment adherence.
引用
收藏
页码:49 / 54
页数:6
相关论文
共 16 条
  • [1] Quality of Life Measures for Acne Patients
    Barnes, Lauren E.
    Levender, Michelle M.
    Fleischer, Alan B., Jr.
    Feldman, Steven R.
    [J]. DERMATOLOGIC CLINICS, 2012, 30 (02) : 293 - +
  • [2] Bowe WP, 2014, J DRUGS DERMATOL, V13, pS89
  • [3] Del Rosso J.Q., 2008, J. Clin. Aesthet. Dermatol, V1, P48
  • [4] Del Rosso James Q, 2013, J Clin Aesthet Dermatol, V6, P19
  • [5] Draelos ZD, 2006, CUTIS, V78, P34
  • [6] Large-scale worldwide observational study of adherence with acne therapy
    Dreno, Brigitte
    Thiboutot, Diane
    Gollnick, Harald
    Finlay, Andrew Y.
    Layton, Alison
    Leyden, James J.
    Leutenegger, Eric
    Perez, Montserrat
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (04) : 448 - 456
  • [7] Garcia RL, 2014, J AM ACAD DERMATOL, V70, pAB11
  • [8] Management of acne - A report from a global alliance to improve outcomes in acne
    Gollnick, H
    Cunliffe, W
    Berson, D
    Dreno, B
    Finlay, A
    Leyden, JJ
    Shalita, AR
    Thiboutot, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (01) : S1 - S37
  • [9] The Relationship of Proper Skin Cleansing to Pathophysiology, Clinical Benefits, and the Concomitant Use of Prescription Topical Therapies in Patients with Acne Vulgaris
    Levin, Jacquelyn
    [J]. DERMATOLOGIC CLINICS, 2016, 34 (02) : 133 - +
  • [10] Russell JJ, 2000, AM FAM PHYSICIAN, V61, P357